Astrana Health, Inc. (3AM.F)
| Previous close | 34.40 |
| Open | 34.60 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 34.60 - 34.60 |
| 52-week range | 27.00 - 41.60 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 1.572B |
| Beta (5Y monthly) | 1.09 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Astrana Health, Inc. Schedules 2024 First Quarter Financial Results Release and Conference Call
Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the first quarter ended March 31, 2024, after the close of the stock market on Tuesday, May 7, 2024. The Company will discuss those results on a conference call at 2:3
- PR Newswire
Astrana Health, Inc. Completes Acquisition of Community Family Care Medical Group IPA, Inc. and Health Plan
Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced it has completed the acquisition relating to Community Family Care Medical Group on March 31, 2024 by closing both the second closing under the Asset and Equity Purchase Agreement and the closing under the Stoc
- PR Newswire
Astrana Health, Inc. Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that effective on March 29, 2024, the Compensation Committee of Astrana's Board of Directors (the "Committee") granted a total of 16,874 shares of restricted common stock to two newly-hired non-executive employ
